Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.69
16.03.22
-
16.03.23
0.48%
16.03.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€54.18
03.03.22
-
03.03.23
4.63%
16.03.22

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€34.29
03.01.22
-
03.01.23
-30.53%
14.03.22

buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€19.50
06.01.22
-
06.01.23
-45.13%
13.03.22

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.90
02.07.21
-
02.07.22
-20.90%
09.03.22

Innovative
Dependend from some customers or products
Higher risks for its business
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€82.98
08.03.21
-
08.03.22
-72.98%
09.03.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Standard Investments for future growth
buy
Paion AG

Start price
Target price
Perf. (%)
€2.23
07.03.21
€5.00
07.03.22
-47.17%
08.03.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€52.40
01.03.22
-
01.03.23
2.48%
02.03.22

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.45
05.12.21
€40.00
05.12.22
-27.32%
01.03.22

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€51.20
28.02.22
-
28.02.23
-0.16%
28.02.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€52.22
03.06.21
-
03.06.22
-2.82%
26.02.22

Revenue growth > 30% per year expected
Undervalued
High Investments for future growth
Top Rating
buy
Bayer AG

Start price
Target price
Perf. (%)
€51.39
21.02.22
-
21.02.23
2.76%
25.02.22

buy
MagForce AG

Start price
Target price
Perf. (%)
€4.62
24.02.21
€9.00
24.02.22
-50.00%
25.02.22

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.45
24.11.21
-
24.11.25
21.92%
23.02.22

buy
Medigene AG

Start price
Target price
Perf. (%)
€3.71
22.02.22
€5.00
22.02.23
18.89%
23.02.22

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
buy
Heidelberg Pharma AG

Start price
Target price
Perf. (%)
€8.98
21.02.21
€10.00
21.02.22
-54.90%
22.02.22

Market Leader or Top 3
Could be very worthwhile Investment >20% year
Known brand
Very Future proof/growth oriented business model
Bayer AG

Start price
Target price
Perf. (%)
€53.28
03.02.22
-
03.02.23
-3.55%
21.02.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€53.36
03.05.21
-
03.05.22
1.07%
16.02.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€54.90
15.02.21
€62.00
15.02.22
-4.21%
15.02.22

buy
Formycon AG

Start price
Target price
Perf. (%)
€67.20
08.02.21
-
08.02.22
-19.79%
09.02.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€54.91
26.04.21
-
26.04.22
-3.24%
08.02.22

buy
Formycon AG

Start price
Target price
Perf. (%)
€67.40
07.02.21
€80.00
07.02.22
-20.03%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€3.55
23.01.22
-
23.01.23
0.17%
06.02.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€56.11
05.02.21
€90.00
05.02.22
-5.54%
05.02.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
buy
Bayer AG

Start price
Target price
Perf. (%)
€54.23
04.02.21
-
04.02.22
-2.27%
05.02.22